Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus

Macias J, Berenguer J, Japon MA, et al. Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus. Hepatology. 2009;50(4):1056-1063.

Publication Type:

Journal Article

Authors:

Macias, J.; Berenguer, J.; Japon, M.A.; et, al

Source:

Hepatology, Volume 50, Issue 4, p.1056-1063 (2009)

Keywords:

Adult, Anti-HIV Agents, Antiretroviral, Antiretroviral Therapy, Antiretroviral Therapy,Highly Active, Antiviral Agents, Biopsy, Cohort Studies, complications, Disease, Disease Progression, drug therapy, epidemiology, Female, Fibrosis, HCV, Hepacivirus, hepatitis, Hepatitis C, hepatitis C virus, Hiv, HIV Infections, HIV RNA, Human, Humans, interferon, Interferon Alfa-2a, Interferon-alpha, Liver, Liver Cirrhosis, Male, Middle Aged, Multivariate Analysis, pathogenicity, pathology, Patients, peginterferon, Plasma, Polyethylene Glycols, Prospective Studies, Proteins, Recombinant Proteins, Research, Research Support, Retrospective Studies, Ribavirin, Risk, Risk Factors, Rna, Serum, Spain, therapeutic use, therapy, Time, treatment, virology

Cited On:

When and in Whom to Initiate HCV Therapy

External Third-party Web Link:

http://www.ncbi.nlm.nih.gov/pubmed/19670415

Export Citation:

RIS Format

Top